CRON logo

Cronos Group Inc. Stock Price

TSX:CRON Community·CA$1.4b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 14 Fair Values set on narratives written by author

CRON Share Price Performance

CA$3.69
1.08 (41.38%)
CA$4.68
Fair Value
CA$3.69
1.08 (41.38%)
21.1% undervalued intrinsic discount
CA$4.68
Fair Value
Price CA$3.69
AnalystConsensusTarget CA$4.68
AnalystLowTarget CA$3.45
AnalystHighTarget CA$5.00

CRON Community Narratives

·
Fair Value CA$4.68 21.1% undervalued intrinsic discount

GrowCo Capacity And Global Markets Will Unlock Potential

0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
·
Fair Value CA$3.45 7.0% overvalued intrinsic discount

Regulatory Shifts In Israel And Germany Will Hinder Cannabis Growth

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value CA$5 26.2% undervalued intrinsic discount

Global Cannabis Legalization Will Expand Wellness And Medicine Markets

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
CA$3.45
7.0% overvalued intrinsic discount
Profit Margin
35.27%
Future PE
16.21x
Price in 2029
CA$4.15

Trending Discussion

Updated Narratives

CRON logo

CRON: Brand Strength And Rescheduling Tailwinds Will Support Future Upside

Fair Value: CA$4.68 21.1% undervalued intrinsic discount
9 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CRON logo

CRON: Partial Rescheduling Expectations Will Constrain Future Earnings Power

Fair Value: CA$3.45 7.0% overvalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CRON logo

Global Cannabis Legalization Will Expand Wellness And Medicine Markets

Fair Value: CA$5 26.2% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with reasonable growth potential.

0 Risks
2 Rewards

Cronos Group Inc. Key Details

US$159.5m

Revenue

US$96.3m

Cost of Revenue

US$63.2m

Gross Profit

US$65.0m

Other Expenses

-US$1.8m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.0049
39.61%
-1.14%
0%
View Full Analysis

About CRON

Founded
n/a
Employees
610
CEO
Michael Gorenstein
WebsiteView website
thecronosgroup.com

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.

Recent CRON News & Updates

Narrative Update Jun 14

CRON: Brand Strength And Rescheduling Tailwinds Will Support Future Upside

Analysts have lifted their CA$ price target on Cronos Group, with an updated fair value of CA$4.68 compared with the prior CA$4.24. This reflects refreshed views on revenue growth, margins, discount rates and future P/E assumptions following recent Street research, including the CA$1 target increase at TD Securities and supportive commentary around partial cannabis rescheduling from Roth Capital.
Narrative Update May 31

CRON: Partial Rescheduling Expectations Will Constrain Future Earnings Power

Analysts have raised Cronos Group's CA$ price target by CA$1, citing updated expectations around revenue growth, margins and future P/E assumptions, as well as recent Street research that includes a CA$1 target increase at TD Securities and favorable perspectives on partial cannabis re-scheduling. Analyst Commentary Recent Street commentary around Cronos Group has focused on how updated revenue expectations, margin trajectories and P/E assumptions feed into revised valuation frameworks.

Recent updates

No updates